According to Nectar Lifesciences 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.478802. At the end of 2023 the company had a P/S ratio of 0.4395.
Year | P/S ratio | Change |
---|---|---|
2023 | 0.4395 | 34.18% |
2022 | 0.3275 | -15.8% |
2021 | 0.3890 | 24.87% |
2020 | 0.3115 | 202.91% |
2019 | 0.1028 |